Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Aug;12(2):295–297. doi: 10.1128/aac.12.2.295

Susceptibility of Organisms in the Mycobacterium fortuitum Complex to Antituberculous and Other Antimicrobial Agents

W Eugene Sanders Jr *, Eldert C Hartwig †, Nathan J Schneider †, Robert Cacciatore †, Henry Valdez †
PMCID: PMC429903  PMID: 900925

Abstract

Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DUNBAR F. P., DAVIS R., JEFFERIES M. B. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test. Am Rev Tuberc. 1958 Feb;77(2):350–355. doi: 10.1164/artpd.1958.77.2.350. [DOI] [PubMed] [Google Scholar]
  2. Dreisin R. B., Scoggin C., Davidson P. T. The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases. Tubercle. 1976 Mar;57(1):49–57. doi: 10.1016/0041-3879(76)90017-9. [DOI] [PubMed] [Google Scholar]
  3. Gale G. L. Atypical mycobacteria in a tuberculosis hospital. Can Med Assoc J. 1976 Apr 3;114(7):612–614. [PMC free article] [PubMed] [Google Scholar]
  4. HARTWIG E. C., CACCIATORE R., DUNBAR F. P. M. fortuitum: its identification, incidence, and significance in Florida. Am Rev Respir Dis. 1962 Jan;85:84–91. doi: 10.1164/arrd.1962.85.1.84. [DOI] [PubMed] [Google Scholar]
  5. Hand W. L., Sanford J. P. Mycobacterium fortuitum--a human pathogen. Ann Intern Med. 1970 Dec;73(6):971–977. doi: 10.7326/0003-4819-73-6-971. [DOI] [PubMed] [Google Scholar]
  6. Hobby G. L., Redmond W. B., Runyon E. H., Schaefer W. B., Wayne L. G., Wichelhausen R. H. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study. Am Rev Respir Dis. 1967 Jun;95(6):954–971. doi: 10.1164/arrd.1967.95.6.954. [DOI] [PubMed] [Google Scholar]
  7. Kubica G. P. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis. 1973 Jan;107(1):9–21. doi: 10.1164/arrd.1973.107.1.9. [DOI] [PubMed] [Google Scholar]
  8. Runyon E. H. Ten mycobacterial pathogens. Tubercle. 1974 Sep;55(3):235–240. doi: 10.1016/0041-3879(74)90051-8. [DOI] [PubMed] [Google Scholar]
  9. Sanders W. E., Cacciatore R., Valdez H., Pejovic I., Dunbar F. P. Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice. J Infect Dis. 1971 Dec;124 (Suppl):S33–S36. doi: 10.1093/infdis/124.supplement_1.s33. [DOI] [PubMed] [Google Scholar]
  10. Wolinsky E., Rynearson T. K. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis. 1968 Jun;97(6):1032–1037. doi: 10.1164/arrd.1968.97.6P1.1032. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES